Lipodystrophy

Lipodystrophy
ICD-10	E88.1
ICD-9	272.6
DiseasesDB	30066
MeSH	D008060

WikiDoc Resources for Lipodystrophy
Articles
Most recent articles on Lipodystrophy Most cited articles on Lipodystrophy Review articles on Lipodystrophy Articles on Lipodystrophy in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Lipodystrophy Images of Lipodystrophy Photos of Lipodystrophy Podcasts & MP3s on Lipodystrophy Videos on Lipodystrophy
Evidence Based Medicine
Cochrane Collaboration on Lipodystrophy Bandolier on Lipodystrophy TRIP on Lipodystrophy
Clinical Trials
Ongoing Trials on Lipodystrophy at Clinical Trials.gov Trial results on Lipodystrophy Clinical Trials on Lipodystrophy at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Lipodystrophy NICE Guidance on Lipodystrophy NHS PRODIGY Guidance FDA on Lipodystrophy CDC on Lipodystrophy
Books
Books on Lipodystrophy
News
Lipodystrophy in the news Be alerted to news on Lipodystrophy News trends on Lipodystrophy
Commentary
Blogs on Lipodystrophy
Definitions
Definitions of Lipodystrophy
Patient Resources / Community
Patient resources on Lipodystrophy Discussion groups on Lipodystrophy Patient Handouts on Lipodystrophy Directions to Hospitals Treating Lipodystrophy Risk calculators and risk factors for Lipodystrophy
Healthcare Provider Resources
Symptoms of Lipodystrophy Causes & Risk Factors for Lipodystrophy Diagnostic studies for Lipodystrophy Treatment of Lipodystrophy
Continuing Medical Education (CME)
CME Programs on Lipodystrophy
International
Lipodystrophy en Espanol Lipodystrophy en Francais
Business
Lipodystrophy in the Marketplace Patents on Lipodystrophy
Experimental / Informatics
List of terms related to Lipodystrophy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lipodystrophy is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. ("Lipo" is Latin for "fat" and "dystrophy" is Latin for "abnormal or degenerative condition".) A more specific term, lipoatrophy is used when describing the loss of fat from one area (usually the face).

Insulin injections

A lipodystrophy can be a lump or small dent in the skin that forms when a person keeps performing injections in the same spot. These types of lipodystrophies are harmless. People who want to avoid them can do so by changing (rotating) the places where they perform injections. For people with diabetes, using purified insulins may also help.

One of the side-effects of lipodystrophy is the rejection of the injected medication, the slowing down of the absorption of the medication, or trauma that can cause bleeding that, in turn, will reject the medication. In either scenarios, the dosage of the medication, such as insulin for diabetics, becomes impossible to gauge correctly and the treatment of the disease for which the medication is administered is impaired thereby allowing the medical condition to worsen.

In some cases, rotation of the injection sites may not be enough to prevent lipodystrophy.

Antiretroviral drugs

Lipodystrophies can be a possible side effect of antiretroviral drugs such as Dolutegravir, lamivudine, Ritonavir, Saquinavir mesylate. Other lipodystrophies manifest as lipid redistribution; with excess, or lack of, fat in various regions of the body. These include, but are not limited to, having sunken cheeks and/or "humps" on the back or back of the neck (also referred to as buffalo hump).

Hereditary forms

Lipodystrophy can be caused by metabolic abnormalities due to genetic issues. These are often characterized by insulin resistance and are associated with Syndrome X.

See also

• Barraquer-Simons disease

External links

• Template:DermAtlas
• TheBody: The Lipoatrophy Resource Center

Template:Lipid metabolism disorders

de:Lipodystrophie nl:Lipodystrofie

Template:WikiDoc Sources